Off-Label Use and the Spectre of Drug-Eluting Stent Thrombosis

被引：1
|
作者：
Cook, Stephane [1 ]
Wenaweser, Peter [1 ]
机构：
[1] Swiss Cardiovasc Ctr, Bern, Switzerland
来源：
CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 2009年 / 2卷 / 04期
关键词：
Editorials; stents; BARE-METAL STENTS; OUTCOMES; IMPLANTATION; PREDICTORS; EFFICACY; THERAPY; SAFETY; RISK;
D O I：
10.1161/CIRCINTERVENTIONS.109.891218
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 276
页数：4
相关论文
共 50 条
  • [21] Peeling-off labels -: Mounting evidence for benefit of drug-eluting stents with off-label use
    Buettner, Heinz Joachim
    Neumann, Franz-Josef
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (21) : 2037 - 2038
  • [22] Stent thrombosis and drug-eluting stents
    Takayama, Tadateru
    Hiro, Takafumi
    Hirayama, Atsushi
    JOURNAL OF CARDIOLOGY, 2011, 58 (02) : 92 - 98
  • [23] Long-Term Predictors of Clinical Events after Off-Label Use of Drug-Eluting Stent beyond 1 Year
    Yun, Kyeong Ho
    Ko, Jum Suk
    Rhee, Sang Jae
    Lee, Eun Mi
    Yoo, Nam Jin
    Kim, Nam-Ho
    Oh, Seok Kyu
    Jeong, Jin-Won
    KOREAN CIRCULATION JOURNAL, 2013, 43 (03) : 161 - 167
  • [24] Comparison of stent thrombosis between on- and off-label use
    Ahn, M. S.
    Lee, K. H.
    Kim, I. Y.
    Yoo, B. S.
    Lee, S. H.
    Choe, K. H.
    Youn, Y. J.
    Kim, S. Y.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 97C - 98C
  • [25] Clinical impact of off-label use of contemporary drug-eluting stents in the randomized TWENTE trial
    Sen, H.
    Tandjung, K.
    Lam, M. K.
    Van Houwelingen, K. G.
    Stoel, M.
    Louwerenburg, J. W.
    De Man, F. H. A. F.
    Linssen, G. C. M.
    Nienhuis, M. B.
    Von Birgelen, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 555 - 555
  • [26] Five-year clinical outcomes of drug-eluting stents according to on-label and off-label use
    Park, Kyu-Hwan
    Kim, Ung
    Lee, Chan-Hee
    Son, Jang-Won
    Park, Jong-Seon
    Shin, Dong-Gu
    Kim, Young-Jo
    Cho, Jeong-Hwan
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (04): : 678 - 684
  • [27] What Off-label Parameter Was the Risk Factor to Target Vessel Failure after Drug-eluting Stent Implantation?
    Kotani, Jun-Ichi
    Adachi, Taichi
    Ikari, Yuji
    Kyo, Eishou
    Kozuma, Ken
    Nakamura, Masato
    Yokoi, Hiroyoshi
    CIRCULATION, 2011, 124 (21)
  • [28] Stent Underexpansion in Early Drug-Eluting Stent Thrombosis
    Kaneda, Hideaki
    Ma, Ji
    Morita, Toshihiro
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (08) : 807 - 807
  • [29] Outcomes and Complications With Off-Label Use of Drug-Eluting Stents Results From the STENT (Strategic Transcatheter Evaluation of New Therapies) Group
    Brodie, Bruce R.
    Stuckey, Thomas
    Downey, William
    Humphrey, Angela
    Bradshaw, Barbara
    Metzger, Chris
    Hermiller, James
    Krainin, Fred
    Juk, Stanley
    Cheek, Barry
    Duffy, Peter
    Smith, Henry
    Edmunds, John
    Varanasi, Jay
    Simonton, Charles A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (04) : 405 - 414
  • [30] Drug-Eluting Stent Event Registry of Thrombosis (DESERT): The International Drug-Eluting Stent Thrombosis Registry, Angiographic Assessment
    Waksman, Ron
    Torguson, Rebecca
    Kaneshige, Kimberly
    Kirtane, Ajay
    Ryan, Thomas
    Raeber, Lorenz
    Applegate, Robert
    Waxman, Sergio
    Cohen, David
    Gordon, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B180 - B181
12345